ALBANY

Handelsplatz Geld-Stk. Geld Geld-Brief Brief Brief-Stk. Spread Zeit

Frankfurt 1.198 2,506 € 2,603 € 1.153 3,87% 13:29:37
Nasdaq 1.300 3,17 $ 3,45 $ 500 8,83% 10:02:01

.....wohl bekommmmmmms ;-)

http://www.ariva.de/news/...c-Contract-with-Knopp-Biosciences-4261251

alles fett in GRÜN so muss das sein,echt grosses Kino hier

-6,17% realtime

Times & Sales: Frankfurt
Zeit Kurs Stück
  15:55:35§2,75 €
                   0          §
  15:55:01§2,743 €
                   0§
15:54:52 2,754 €
          §0
der Deutsche war heute auch faul "Schuldigung,ich hätte besser schreiben sollen der Ami hat sich schon die ersten Scheine in's Depot gezogen und cash zahlen lassen und nicht überwiegend gekauft und gepusht,ich nenne das aber trotzdem faul - aber ich hab mich dafür entschuldigt,buran

hättest Du schreiben sollen,ich brauch das für mein Ego ;o) ...-6,17%RT

Geld- und Briefkurse
Handelsplatz Geld-Stk.      GeldGeld-Brief     BriefBrief-Stk.§Spread Zeit

Nasdaq 100 3,26 $ 4,00 $ 2.000 22,70% 15:02:27
__________________________________________________
so das derzeitige Angebot

Geld- und Briefkurse
Handelsplatz Geld-Stk.      GeldGeld-Brief     BriefBrief-Stk.§Spread Zeit

Nasdaq 100 3,26 $ 4,00 $ 2.000 22,70% 15:12:10
__________________________________________________
bittesehr das ist Dein Preis,buran

aber nur wenn sie Devisen bringen in's Land also Depot,eben Export Import so wie die ganz Grossen das machen ;-)
+1,11%

http://www.youtube.com/watch?v=hR-KRWeAU6I

;)

von Norton Green oder was weiss ich was der da singt
___________________________________________
jetzt kommt's unterm Strich,das was man nennt Bilanz
___________________________________________
ALBANY MOLEC. 2,724 € +1,11% Perf. seit Threadbeginn:   +37,14%
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
Gruss buran

Kauflaune gut vorhanden

zeigt grüne Prozente und die sind derzeit Tageshoch,aber noch kein Ende also Handelsschluss,geiles Rennen

.....Aktienanzahl§30,8 Mio. (Stand: 11.08.12) << auch mal ein Augenmerk wert

buran

Handelsplatz Geld-Stk. Geld Geld-Brief Brief Brief-Stk. Spread Zeit
Frankfurt 1.093 2,746 € 2,853 € 1.052 3,90% 15:15:45
Nasdaq 100 3,42 $ 4,00 $ 2.000 16,96% 15:16:38
.....und beide Plätze handelbar,also ansteuerbar

da wäre schon etwas mehr drin,nur man beachte die Zählerprozente beim DAX,zartes rot
trotzdem wacker ;-)))

und so sieht's aus:  
Nasdaq 1.000 3,50 $ 3,57 $ 100 2,00% 10:02:01
spread eierflach,viel GLÜCK

machen gute Arbeit ..einfach die Prozente ansehen ..Börse wie sie singt und lacht

MRI Announces Five-Year Extension of API Supply Agreement With Shire

22:05 18.10.12

PR Newswire

ALBANY, N.Y., Oct. 18, 2012

ALBANY, N.Y., Oct. 18, 2012 /PRNewswire/ -- AMRI (NASDAQ: AMRI) announced today that it has entered into a multi-year supply agreement for an undisclosed product with Shire US Manufacturing Inc., whose parent company, Shire plc (LSE: SHP, NASDAQ: SHPGY), is a global company that focuses its business on behavioral health, gastro intestinal diseases, rare diseases and regenerative medicine. The agreement extends a previously existing agreement between the two companies. The terms of the agreement are confidential.  

(Logo:  photos.prnewswire.com/prnh/20120229/NY61160LOGO )

"We are pleased to extend this agreement with Shire," said Thomas E. D'Ambra, Ph.D., Chairman, President and Chief Executive Officer of AMRI. "Our partnership lays the groundwork for AMRI to be considered by Shire for future development and manufacturing opportunities."

About AMRI

Albany Molecular Research, Inc. (AMRI) is a global contract research and manufacturing organization offering customers fully integrated drug discovery, development, and manufacturing services. For over 21 years AMRI has demonstrated its adaptability as the pharmaceutical and biotechnology industries have undergone tremendous change in response to multiple challenges. This experience, a track record of success and locations in the United States, Europe and Asia now provides our customers with SMARTSOURCING™, a full range of value-added opportunities providing customers informed decision-making, enhanced efficiency and more successful outcomes at all stages of the pipeline. AMRI has also successfully partnered R&D programs and is actively seeking to out-license its remaining programs for further development. For press releases and additional information about the company, please visit www.amriglobal.com.

SOURCE AMRI
Quelle: PR Newswire

news >> http://www.ariva.de/news/...cal-Development-and-Manufacturing-4306500

AMRI to Announce Third Quarter Results

13:05 30.10.12

PR Newswire

ALBANY, N.Y., Oct. 30, 2012

ALBANY, N.Y., Oct. 30, 2012 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced it will issue third quarter financial results before the opening of the market on Tuesday, November 6, 2012.  Following the release of its results, the company will host a conference call and simultaneous webcast at 10 a.m. ET.

(Logo: photos.prnewswire.com/prnh/20120229/NY61160LOGO)

The conference call can be accessed by dialing 888-364-3108 (domestic calls) or 719-457-2645 (international calls) at 9:45 a.m. ET and entering passcode 8248928.  The webcast will be available live via the Internet and can be accessed on the company's website at www.amriglobal.com.  Replays of the webcast can also be accessed for up to 90 days after the call via the investor area of the company's website at www.amriglobal.com/investor_relations/.

About AMRI

Albany Molecular Research, Inc. (AMRI) is a global contract research and manufacturing organization offering customers fully integrated drug discovery, development, and manufacturing services. For over 21 years AMRI has demonstrated its adaptability as the pharmaceutical and biotechnology industries have undergone tremendous change in response to multiple challenges. This experience, a track record of success and locations in the United States, Europe and Asia now provides our customers with SMARTSOURCING™, a full range of value-added opportunities providing customers informed decision-making, enhanced efficiency and more successful outcomes at all stages of the pipeline. AMRI has also successfully partnered R&D programs and is actively seeking to out-license its remaining programs for further development.

SOURCE AMRI
Quelle: PR Newswire

http://www.ariva.de/news/...ounces-Third-Quarter-2012-Results-4328597
buran

......... ;-)

abartig genial in den Zenit und weiter mit der Kursballerei 10-9-8-7-6-5-4-3-2-1-zero undddddddd ne donnernde RAKETE ;-) Börse ist so schön

Handelsplatz Geld-Stk. Geld Geld-Brief Brief Brief-Stk. Spread Zeit
Frankfurt 1.074 2,794 € 2,902 € 1.034 3,87% 10:08:58
__________________________________________________
..bitte slebst wählen,GrB